Naoyuki Taniguchi Selected Research

Oligosaccharides

1/2015	Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers.
2/2013	Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.
7/2009	Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.
10/2008	Potential of N-glycan in cell adhesion and migration as either a positive or negative regulator.
7/2008	Functional roles of N-glycans in cell signaling and cell adhesion in cancer.
9/2007	Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary cutaneous malignant melanoma.
6/2006	Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.
5/2006	Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation.
3/2006	Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
1/2005	Expression of N-acetylglucosaminyltransferase V in the development of human esophageal cancers: immunohistochemical data from carcinomas and nearby noncancerous lesions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoyuki Taniguchi Research Topics

Disease

71	Neoplasms (Cancer) 01/2023 - 02/2002
21	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2002
18	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 03/2005
15	Emphysema 01/2023 - 11/2005
15	Hepatocellular Carcinoma (Hepatoma) 12/2017 - 08/2002
11	Chronic Obstructive Pulmonary Disease (COPD) 10/2023 - 07/2012
11	Inflammation (Inflammations) 01/2021 - 03/2002
10	Carcinogenesis 01/2022 - 04/2002
9	Carcinoma (Carcinomatosis) 10/2016 - 01/2005
8	Atherosclerosis 05/2012 - 03/2002
7	Stomach Neoplasms (Stomach Cancer) 10/2016 - 04/2002
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2016 - 05/2003
6	Colonic Neoplasms (Colon Cancer) 09/2010 - 01/2004
5	Lung Neoplasms (Lung Cancer) 10/2023 - 03/2004
5	Melanoma (Melanoma, Malignant) 10/2022 - 09/2007
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2013 - 03/2006
3	Infections 03/2024 - 11/2002
3	Colitis 03/2019 - 05/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 09/2012 - 10/2003
3	Neuroblastoma 01/2010 - 01/2006
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 11/2022 - 10/2005
2	Diabetes Complications 11/2019 - 11/2012
2	Experimental Melanoma 01/2019 - 02/2002
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 01/2016
2	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 06/2013
2	Breast Neoplasms (Breast Cancer) 11/2016 - 11/2013
2	Nervous System Diseases (Neurological Disorders) 11/2016 - 01/2004
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016 - 01/2016
2	Disease Progression 04/2014 - 07/2012
2	Acute Coronary Syndrome 10/2013 - 11/2012

Drug/Important Bio-Agent (IBA)

55	Polysaccharides (Glycans)IBA 03/2024 - 07/2003
33	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2002
26	EnzymesIBA 12/2022 - 01/2002
16	FucoseIBA 10/2023 - 11/2002
16	Biomarkers (Surrogate Marker)IBA 10/2023 - 02/2006
15	LectinsIBA 01/2023 - 02/2002
15	GlycosyltransferasesIBA 01/2022 - 05/2002
15	OligosaccharidesIBA 01/2015 - 02/2002
13	Glycoproteins (Glycoprotein)IBA 03/2024 - 05/2002
13	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 01/2018 - 01/2004
10	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2005
10	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 06/2006
8	SugarsIBA 01/2021 - 09/2007
7	AsparagineIBA 01/2022 - 03/2004
7	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 11/2005
7	Cadherins (E-Cadherin)IBA 10/2016 - 05/2008
7	Peptides (Polypeptides)IBA 02/2015 - 03/2005
6	IntegrinsIBA 03/2024 - 05/2008
5	FucosyltransferasesIBA 10/2023 - 01/2015
5	Keratan SulfateIBA 01/2023 - 01/2017
5	NucleotidesIBA 01/2021 - 07/2010
5	SmokeIBA 01/2017 - 06/2007
5	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 03/2005
5	Superoxide Dismutase-1IBA 02/2014 - 01/2002
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2010 - 10/2006
4	Pancreatic Elastase (Elastase)IBA 01/2023 - 07/2012
4	DisaccharidesIBA 01/2023 - 01/2017
4	Messenger RNA (mRNA)IBA 05/2017 - 04/2002
4	LigandsIBA 05/2012 - 01/2004
4	AcetylglucosamineIBA 01/2011 - 05/2006
3	Amyloid beta-PeptidesIBA 03/2024 - 11/2007
3	TransferasesIBA 01/2021 - 02/2006
3	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2017 - 02/2013
3	AntioxidantsIBA 01/2016 - 01/2002
3	ZincIBA 01/2015 - 01/2002
3	Cell Adhesion MoleculesIBA 03/2013 - 11/2002
3	RNA (Ribonucleic Acid)IBA 03/2013 - 02/2005
3	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 09/2010 - 03/2005
3	Guanosine Diphosphate (GDP)IBA 07/2010 - 11/2002
3	Uridine Diphosphate (UDP)IBA 07/2010 - 02/2002
3	Monoclonal AntibodiesIBA 02/2009 - 01/2005
3	HaptoglobinsIBA 05/2008 - 08/2002
3	PhytohemagglutininsIBA 09/2007 - 03/2004
3	matriptaseIBA 05/2006 - 05/2002
2	Mannose (D-Mannose)IBA 01/2023 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 11/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 04/2002
2	N-AcetylglucosaminyltransferasesIBA 01/2021 - 03/2013
2	GlycolipidsIBA 01/2021 - 01/2004
2	Advanced Glycation End ProductsIBA 11/2019 - 06/2016
2	Dextrans (Dextran)FDA Link 03/2019 - 05/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 08/2004
2	Guanosine Diphosphate Fucose (GDP Fucose)IBA 12/2017 - 12/2007
2	AntibodiesIBA 01/2017 - 11/2002
2	CuprizoneIBA 01/2017 - 06/2013
2	CytokinesIBA 01/2017 - 01/2016
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 10/2016 - 03/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016 - 02/2003
2	Reactive Nitrogen SpeciesIBA 04/2016 - 03/2002
2	GlycoconjugatesIBA 01/2016 - 10/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014 - 07/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2014 - 01/2002
2	Tissue Inhibitor of Metalloproteinase-1IBA 12/2013 - 01/2008
2	Neuregulin-1 (Neuregulin 1)IBA 11/2013 - 03/2007
2	Indicators and Reagents (Reagents)IBA 10/2013 - 11/2012
2	DNA (Deoxyribonucleic Acid)IBA 03/2013 - 03/2006
2	AntigensIBA 02/2013 - 09/2010
2	Scavenger Receptors (Scavenger Receptor)IBA 05/2012 - 11/2009
2	Lipoproteins (Lipoprotein)IBA 05/2012 - 06/2002

Therapy/Procedure

7	Therapeutics 01/2022 - 02/2010